07/08/2019 SOURCE: www.fiercebiotech.com
Two months after Merck announced a billion-dollar plus deal to buy out late-stage cancer biotech Peloton, some of its staffers are finding new homes. Skyhawk Therapeutics nabs Peloton exec and cancer R&D veteran as VP of oncology biology
-
(0)
-
Bookmark
- Comments. (0)
Chris Feix
Topics: Pesticides, Beekeeping, Pest Control, Government / Policies,
-
(1)
-
Bookmark
- Comments (0)
Brandon Lance
-
(1)
-
Bookmark
- Comments (0)
-
(0)
-
Bookmark
- Comments (0)
Randy Krotz
-
(2)
-
Bookmark
- Comments (0)
Randy Krotz
-
(2)
-
Bookmark
- Comments (0)
Randy Krotz
-
(2)
-
Bookmark
- Comments (0)
Randy Krotz
Topics: World Population,
"...across all of the world’s developed economies, the current fertility pattern has held for so long that it seems likely to remain a stable feature of human society."
-
(2)
-
Bookmark
- Comments (0)
John LaRose Jr.
